Table 2.
Neurological disorders | The function of polarized microglia | Model | Drugs (M2→M1) |
---|---|---|---|
Alzheimer’s disease (AD) | M1 phenotypic inhibits Aβ clearance, while M2 phenotypic enhances Aβ clearance. | Mouse model | DSP-8658 Bexarotene |
Parkinson’s disease (PD) | Dopaminergic degeneration is associated with microglial polarization. | Mouse model | Rosiglitazone |
Amyotrophic lateral sclerosis (ALS) | Elimination of apoptotic cells, production of growth factors, maintenance of synapse structure and function are the main function of microglia. | Mouse model | Minocycline Rho kinase inhibitor[114] Hirsutella sinensis |
Huntington’s disease (HD) | Microglial polarization affects striatal neuronal dysfunction. | Mouse model | Minocycline |
Multiple Sclerosis (MS) | M1 microglia have a greater antigen presenting ability, leading to demyelination and neurodegeneration. While M2 microglia protect oligodendrocytes and neurons from damage and ameliorate disease severity. | Clinical phase IIb |
Anti-pathogenic human endogenous retrovirus type W envelope protein (pHERV-W ENV) |
Neurological disorders | The function of polarized microglia | Model | Drugs (M2→M1) |